000145737 001__ 145737
000145737 005__ 20230915100930.0
000145737 037__ $$aDZNE-2020-01022
000145737 041__ $$aEnglish
000145737 082__ $$a610
000145737 1001_ $$0P:(DE-HGF)0$$aSchultz, Stephanie$$b0
000145737 1112_ $$a144th Annual Meeting American Neurological Association$$cSt. Louis, Mo$$d2019-10-13 - 2019-10-15$$gANA 2019$$wUSA
000145737 245__ $$aM148. Association between Serum Neurofilament Lightand Established White Matter Neuroimaging Markers inAutosomal Dominant Alzheimer Disease
000145737 260__ $$c2019
000145737 3367_ $$0PUB:(DE-HGF)1$$2PUB:(DE-HGF)$$aAbstract$$babstract$$mabstract$$s1598432296_4498
000145737 3367_ $$033$$2EndNote$$aConference Paper
000145737 3367_ $$2BibTeX$$aINPROCEEDINGS
000145737 3367_ $$2DRIVER$$aconferenceObject
000145737 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$mjournal
000145737 3367_ $$2DataCite$$aOutput Types/Conference Abstract
000145737 3367_ $$2ORCID$$aOTHER
000145737 520__ $$aBackground: White matter (WM) alterations are a commonfeature of Alzheimer Disease (AD), typically detected in vivowith diffusion tensor imaging (DTI). Blood-based neurofila-ment light (NfL) is an emerging biomarker for monitoringneurodegeneration. While NfL is thought to reflect damageto myelinated axons, minimal work has directly examinedthis association. The objective of this study was to examinethe cross-sectional and longitudinal relationship betweenWM neuroimaging markers and serum NfL levels.
000145737 536__ $$0G:(DE-HGF)POF3-342$$a342 - Disease Mechanisms and Model Systems (POF3-342)$$cPOF3-342$$fPOF III$$x0
000145737 7001_ $$0P:(DE-HGF)0$$aAdedokun, Adedamola$$b1
000145737 7001_ $$0P:(DE-HGF)0$$aStrain, Jeremy$$b2
000145737 7001_ $$0P:(DE-HGF)0$$aWang, Qing$$b3
000145737 7001_ $$0P:(DE-2719)2811828$$aPreische, Oliver$$b4$$udzne
000145737 7001_ $$0P:(DE-HGF)0$$aKuhle, Jens$$b5
000145737 7001_ $$0P:(DE-HGF)0$$aMorris, John$$b6
000145737 7001_ $$0P:(DE-HGF)0$$aBateman, Randall$$b7
000145737 7001_ $$0P:(DE-2719)2000010$$aJucker, Mathias$$b8$$udzne
000145737 7001_ $$0P:(DE-HGF)0$$aBenzinger, Tammie$$b9
000145737 7001_ $$0P:(DE-HGF)0$$aGordon, Brian$$b10
000145737 773__ $$0PERI:(DE-600)2037912-2$$nS23$$pS145 - S146$$tAnnals of neurology$$v86$$x0364-5134$$y2019
000145737 8564_ $$uhttps://onlinelibrary.wiley.com/doi/epdf/10.1002/ana.25587
000145737 909CO $$ooai:pub.dzne.de:145737$$pVDB
000145737 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811828$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000145737 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000010$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b8$$kDZNE
000145737 9131_ $$0G:(DE-HGF)POF3-342$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$aDE-HGF$$bForschungsbereich Gesundheit$$lErkrankungen des Nervensystems$$vDisease Mechanisms and Model Systems$$x0
000145737 9141_ $$y2019
000145737 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2020-02-26$$wger
000145737 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-02-26
000145737 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-02-26
000145737 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-30$$wger
000145737 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bANN NEUROL : 2021$$d2022-11-30
000145737 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-30
000145737 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-30
000145737 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-30
000145737 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-30
000145737 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-30
000145737 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-30
000145737 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-30
000145737 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-30
000145737 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-30
000145737 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bANN NEUROL : 2021$$d2022-11-30
000145737 9201_ $$0I:(DE-2719)1210001$$kAG Jucker$$lCell Biology of Neurologic Diseases$$x0
000145737 980__ $$aabstract
000145737 980__ $$aVDB
000145737 980__ $$ajournal
000145737 980__ $$aI:(DE-2719)1210001
000145737 980__ $$aUNRESTRICTED